Application Nr Approved Date Route Status External Links
BLA022575 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Vpriv Is Indicated For Long-Term Enzyme Replacement Therapy (Ert) For Patients With Type 1 Gaucher Disease. Vpriv Is A Hydrolytic Lysosomal Glucocerebroside-Specific Enzyme Indicated For Long-Term Enzyme Replacement Therapy (Ert) For Patients With Type 1 Gaucher Disease ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Velaglucerase Alfa

Comments